Graceway Pharmaceuticals
Stage
Acquired | AcquiredValuation
$0000About Graceway Pharmaceuticals
Graceway Pharmaceuticals is a pharmaceutical company focused on acquiring, in-licensing, and developing branded prescription pharmaceutical products. Current prescription products marketed by Graceway include Zyclara(R) (imiquimod) Cream, 3.75%, Aldara(R) (imiquimod) Cream, 5%, Maxair(R) Autohaler(R) (pirbuterol acetate inhalation aerosol), Atopiclair(R) Nonsteroidal Cream, and Estrasorb(R) (estradiol topical emulsion). Zyclara(R), Aldara(R), Maxair(R) Autohaler(R), Atopiclair(R), and Estrasorb(R) are trademarks owned by or licensed to Graceway. In December 2011, Graceway Pharmaceuticals was acquired by Medicis Pharmaceutical. The valuation of Graceway Pharmaceuticals was $455 million.
Missing: Graceway Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Graceway Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Graceway Pharmaceuticals Patents
Graceway Pharmaceuticals has filed 5 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/13/2009 | 7/19/2011 | Skin care, Skin, Dermatologic terminology, Amines, Hairdressing | Grant |
Application Date | 10/13/2009 |
|---|---|
Grant Date | 7/19/2011 |
Title | |
Related Topics | Skin care, Skin, Dermatologic terminology, Amines, Hairdressing |
Status | Grant |
Latest Graceway Pharmaceuticals News
Feb 18, 2012
Medicis Pharmaceutical Corp. (NYSE:MRX) recently announced that it has completed the acquisition of Graceway Pharmaceuticals, LLC. In November last year, Medicis first announced that it had successfully bid for the purchase of Graceway Pharma at the latter’s bankruptcy auction. Graceway Pharma had filed for bankruptcy in September 2011. According to the terms of the bid, Medicis paid $455 million to Graceway Pharma in return of its pharmaceutical product portfolio, consisting of dermatolog
Graceway Pharmaceuticals Frequently Asked Questions (FAQ)
Where is Graceway Pharmaceuticals's headquarters?
Graceway Pharmaceuticals's headquarters is located at 340 Martin Luther King Jr Blvd, Bristol.
What is Graceway Pharmaceuticals's latest funding round?
Graceway Pharmaceuticals's latest funding round is Acquired.
Who are the investors of Graceway Pharmaceuticals?
Investors of Graceway Pharmaceuticals include Medicis Pharmaceutical and Galderma.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.